Core Viewpoint - The company Novozymes (688105.SH) has announced its GLP-1 product line and solutions, which primarily provide essential raw materials and reagents needed for the biological fermentation production of Semaglutide for downstream customers [1] Group 1 - The product offerings include highly specific and high-capacity raw enzymes and various specifications of intermediate peptides, accompanied by comprehensive quality control testing kits [1] - The company has successfully supplied hundreds of kilograms to multiple domestic clients [1] - To meet diverse customer needs, the company offers customized process optimization solutions to help clients improve production efficiency [1] Group 2 - Currently, the company does not engage in the production of related weight-loss drugs [1]
诺唯赞(688105.SH):截至目前,公司不涉及相关减肥药物的生产